Latest news articles

Added 2 months ago Drug news

FDA accepts filing of NDA application for bimatoprost sustained-release for reduction of intraocular pressure in patients with primary open-angle glaucoma or ocular hypertension. Allergan/Abbvie

Allergan plc, has announced that the FDA has accepted the company's New Drug Application (NDA) for Bimatoprost Sustained-Release (SR). Bimatoprost...

Added 6 months ago Drug news

FDA approves Rocklatan in glaucoma or ocular hypertension

Aerie Pharmaceuticals announced that the FDA has approved Rocklatan (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% to reduce elevated intraocular pressure...

Added 8 months ago Drug news

Phase III trial success for brimatoprost SR in reduction of intraocular pressure.- Allergan

Allergan announced positive 3-month topline results from the second pivotal clinical trial of bimatoprost SR , a first-in-class sustained-release, biodegradable...

Search all news articles for Glaucoma

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Chronic Lymphocytic Leukaemia (CLL)

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

+ 1 more



See information on best practice in solid organ transplantation, and expert discussions on related hot topics.

Load more


Glaucoma: diagnosis and management

This guideline covers diagnosing and managing glaucoma in people aged 18 and over. It includes recommendations on testing and referral (case-finding) for chronic open angle glaucoma and ocular hypertension, and on effective diagnosis...

Added 10 years ago

Search all guidelines for Glaucoma